These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10752047)

  • 21. Lipodystrophy--introduction.
    TreatmentUpdate; 2001; 13(7):2-3. PubMed ID: 11794857
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of efavirenz compared with protease inhibitors in the body fat changes associated with highly active antiretroviral therapy.
    Pérez-Molina JA; Domingo P; Martínez E; Moreno S
    J Antimicrob Chemother; 2008 Aug; 62(2):234-45. PubMed ID: 18480167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HAART attack: metabolic disorders during long-term antiretroviral therapy.
    David E
    BETA; 1999 Apr; 12(2):10-4. PubMed ID: 11366674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors.
    Moreno-Pérez O; Escoín C; Serna-Candel C; Picó A; Alfayate R; Merino E; Reus S; Boix V; Sanchez-Paya J; Portilla J
    AIDS; 2010 Jan; 24(2):255-64. PubMed ID: 19915446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in lipid metabolism of patients infected by human immunodeficiency virus. A pathogenic hypothesis].
    Rodríguez Vidigal FF; Muñoz Sanz A
    Med Clin (Barc); 2000 Jun; 115(4):145-50. PubMed ID: 10996887
    [No Abstract]   [Full Text] [Related]  

  • 26. A chat with HIV specialists: the Geneva report.
    Newsline People AIDS Coalit N Y; 1998 Sep; ():12-7. PubMed ID: 11367483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body-fat abnormalities in patients with HIV: progress and challenges.
    Bedimo RJ
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(6):292-305. PubMed ID: 19056708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lipodystrophy syndrome in HIV infection].
    Hartmann M; Petzoldt D
    Hautarzt; 2000 Mar; 51(3):159-63. PubMed ID: 10789076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current concepts of metabolic abnormalities in HIV patients: focus on lipodystrophy.
    Kolter DP
    AIDS Read; 2003 Dec; 13(12 Suppl):S5-13. PubMed ID: 14959694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretoviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis.
    Nolan D; John M; Mallal S
    Antivir Ther; 2001 Sep; 6(3):145-60. PubMed ID: 11808750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HAL in 2001: a fat oddity.
    Grinberg L; Torres G
    GMHC Treat Issues; 1999 Mar; 13(3):2-5, 8. PubMed ID: 11366203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV lipodystrophy: a review.
    Kravcik S
    HIV Clin Trials; 2000; 1(3):37-50. PubMed ID: 11590504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antiretroviral treatment for HIV and adipose tissue].
    Caron M; Bastard JP; Auclair M; Vigouroux C; Capeau J
    Journ Annu Diabetol Hotel Dieu; 2003; ():147-58. PubMed ID: 12868307
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipodystrophy: a new phenomenon?
    Boyle BA
    AIDS Read; 1999; 9(1):15-7. PubMed ID: 12728877
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.
    Martinez E; Mocroft A; García-Viejo MA; Pérez-Cuevas JB; Blanco JL; Mallolas J; Bianchi L; Conget I; Blanch J; Phillips A; Gatell JM
    Lancet; 2001 Feb; 357(9256):592-8. PubMed ID: 11558485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic complications of HIV and AIDs.
    Briggs JM; Drabek CA
    Orthop Nurs; 2001; 20(4):41-50. PubMed ID: 12025672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cohort studies: what do they tell us?
    Chêne G
    J HIV Ther; 2001 May; 6(2):28-31. PubMed ID: 11501200
    [No Abstract]   [Full Text] [Related]  

  • 39. Unsolved mystery of fat redistribution.
    STEP Perspect; 1999; 99(1):6-7. PubMed ID: 11367164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of sex and race on lipodystrophy pathogenesis.
    Nolan D; Mallal S
    J HIV Ther; 2001 May; 6(2):32-6. PubMed ID: 11501201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.